Bought more nvo on the dip to dca. This is a wide moat high quality company. The fundamentals are still strong nothing has changed except the share price so gonna use this weakness to build a bigger position in my portfolio
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
- Valerie Archibald·04-19TOPLLY just crushed NVO with latest drug results. Now Novo is out of the competition. Good luck being a bagholderLikeReport
- Mortimer Arthur·04-19will see quick rebound to $65 and moreLikeReport
- DeltaDrift·04-18High quality stock sure to dcaLikeReport